IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow IQV
IQVIA Holdings Inc. (IQV) Return on equity
IQVIA Holdings Inc.'s return on equity over the twelve months to 30 June 2026 was 22.8%, up 1.3 percentage points from fiscal 2025 (21.4%). Over the past ten years it has ranged from −74.4% (fiscal 2015) to 22.9% (fiscal 2023); the current reading is higher than 82% of that period. That is above the Diagnostics & Research industry median of −2.92% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 21.4% | (1.13) |
| FY2024 | 22.6% | (0.32) |
| FY2023 | 22.9% | 4.39 |
| FY2022 | 18.5% | 2.80 |
| FY2021 | 15.7% | 11.23 |
| FY2020 | 4.45% | 1.56 |
| FY2019 | 2.89% | (0.52) |
| FY2018 | 3.41% | (11.52) |
| FY2017 | 14.9% | 13.24 |
| FY2016 | 1.69% | 76.11 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 74.2% |
| ILMN Illumina, Inc. compare | 32.4% |
| IQV IQVIA Holdings Inc. | 22.8% |
| A Agilent Technologies, Inc. compare | 21.0% |
| DGX Quest Diagnostics Incorporated compare | 14.0% |
| LH Labcorp Holdings Inc. compare | 11.7% |
| WAT Waters Corporation compare | 1.92% |
| NTRA Natera, Inc. compare | −12.5% |
| MTD Mettler-Toledo International, Inc. compare | −736.4% |
| Diagnostics & Research industry median | −2.92% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on IQV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement